Allen Institute Launches $400M Brain Health Accelerator
The Allen Institute launched its Brain Health accelerator earlier this month, with $400 million in commitments over a 14-year initiative. The program’s initial disease targets are in neurodegeneration: Alzheimer’s, Parkinson’s, Huntington’s, ALS, and Lewy body dementia.